==== Front Redox BiolRedox BiolRedox Biology2213-2317Elsevier S2213-2317(18)30461-010.1016/j.redox.2018.07.012Research PaperPomegranate prevents binge alcohol-induced gut leakiness and hepatic inflammation by suppressing oxidative and nitrative stress Cho Young-Eun Song Byoung-Joon bj.song@nih.gov⁎Section of Molecular Pharmacology and Toxicology, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD 20892, USA⁎ Corresponding author. bj.song@nih.gov20 7 2018 9 2018 20 7 2018 18 266 278 30 5 2018 28 6 2018 19 7 2018 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Alcoholic liver disease (ALD) is a major chronic liver disease worldwide and can range from simple steatosis, inflammation to fibrosis/cirrhosis possibly through leaky gut and systemic endotoxemia. We investigated whether pomegranate (POM) protects against binge alcohol-induced gut leakiness, endotoxemia, and inflammatory liver damage. After POM pretreatment for 10 days, rats were exposed to 3 oral doses of binge alcohol (5 g/kg/dose) or dextrose (as control) at 12-h intervals. Binge alcohol exposure induced leaky gut with significantly elevated plasma endotoxin and inflammatory fatty liver by increasing the levels of oxidative and nitrative stress marker proteins such as ethanol-inducible CYP2E1, inducible nitric oxide synthase, and nitrated proteins in the small intestine and liver. POM pretreatment significantly reduced the alcohol-induced gut barrier dysfunction, plasma endotoxin and inflammatory liver disease by inhibiting the elevated oxidative and nitrative stress marker proteins. POM pretreatment significantly restored the levels of intestinal tight junction (TJ) proteins such as ZO-1, occludin, claudin-1, and claundin-3 markedly diminished after alcohol-exposure. In addition, the levels of gut adherent junction (AJ) proteins (e.g., β-catenin and E-cadherin) and desmosome plakoglobin along with associated protein α-tubulin were clearly decreased in binge alcohol-exposed rats but restored to basal levels in POM-pretreated rats. Immunoprecipitation followed by immunoblot analyses revealed that intestinal claudin-1 protein was nitrated and ubiquitinated in alcohol-exposed rats, whereas these modifications were significantly blocked by POM pretreatment. These results showed for the first time that POM can prevent alcohol-induced gut leakiness and inflammatory liver injury by suppressing oxidative and nitrative stress. Abbreviations POM, pomegranateALD, alcoholic liver diseaseTJ, tight junctionAJ, adherent junctionCYP2E1, ethanol-inducible cytochrome P450-2E1iNOS, inducible nitric oxide synthasenitroxidative stress, oxidative and nitrative stressKI mice, knock-in miceKO mice, knock-out miceUA, urolithin AEA, Ellagic acidCMZ, chlormethiazoleBAC, blood alcohol concentrationER, endoplasmic reticulumTLR4, toll-like receptor-4PERK, protein kinase-like endoplasmic reticulum kinaseelF2α, eukaryotic translation initiation factor-2αPDI, protein disulfide isomerasePTM, post-translational modificationROS, reactive oxygen speciesTEER, trans-epithelial electrical resistanceFITC-D4, FITC-labeled 4-kDa dextranIP, immunoprecipitationJNK, c-Jun N-terminal protein kinaseLPS, lipopolysaccharideKeywords Binge alcoholOxidative and nitrative stressGut leakinessInflammatory fatty liver diseaseTight and adherent junction proteins ==== Body 1 Introduction Chronic and/or binge alcohol (ethanol) consumption is known to cause alcoholic liver disease (ALD), which is one of the leading causes of hepatic diseases and liver-related death worldwide [1], [2], [3]. The clinical spectrum of ALD includes alcoholic fatty liver (steatosis), steatohepatitis (inflammation), fibrosis/cirrhosis, and increased risk of hepatocellular carcinoma [1], [3]. Alcohol can directly affect the physiological functions of different liver cells including hepatocytes, Kupffer cells and stellate cells. In addition, alcohol can indirectly stimulate the liver injury by changing gut microbiome accompanied with the impaired gut barrier function, leading to increased leaky gut and translocation of intestinal bacteria with elevated plasma levels of bacterial endotoxin (e.g., lipopolysaccharide, LPS) [4], [5], [6]. Many recent reports showed that circulating LPS can reach the liver via portal vein and interact with hepatic toll-like receptor-4 (TLR4) to initiate the inflammatory cascades for the accelerated development of ALD [4], [5], [6]. Alcohol-induced gut leakiness is critically important in the progression to more severe ALD such as fibrosis/cirrhosis since the elevated levels of endotoxin are correlated with the development of liver cirrhosis [7]. Under the influence of ethanol, the expression and the levels of many genes and proteins are altered through transcriptional and post-transcriptional mechanisms, including epigenetics [8]. The ethanol-inducible cytochrome P450-2E1 (CYP2E1) is one of the well-characterized proteins that are induced and/or activated by chronic and/or binge alcohol intake [9]. Under relative low amounts of alcohol, hepatic and gastric alcohol dehydrogenases usually metabolize alcohol. However, after long-term alcohol drinking or under high blood alcohol concentration (BAC), CYP2E1 becomes involved in the ethanol metabolism (Km about ~ 10 mM ethanol), resulting in the production of acetaldehyde and reactive oxygen species (ROS), which can negatively affect many cellular components and can cause cell death [10]. Death of parenchymal cells can activate liver-resident inflammatory cells such as Kupffer cells or infiltrated neutrophils that can significantly promote inflammatory ALD and severe disease [2], [9], [11]. Indeed, the specific involvement of CYP2E1 in ALD has been demonstrated by utilizing CYP2E1 overexpressed transgenic (Tg), knock-out (KO), and knock-in (KI) mice [2], [12], [13]. Recently, our group reported that CYP2E1 is also involved in n-6 fatty acid containing western-style high-fat diet induced non-alcoholic steatohepatitis [14] and aging-related liver and kidney damage [15], [16] through increasing the oxidative and nitrative (nitroxidative) stress. Furthermore, both intestinal and hepatic CYP2E1 induced (i.e., via protein stabilization) by chronic alcohol drinking [17] or binge alcohol exposure seems critically important in promoting alcohol-mediated increased nitroxidative stress, gut leakage, and endotoxemia, contributing to apoptosis of hepatocytes and steatohepatitis [18], [19]. Pomegranate (POM, Punica granatum) is one of the edible fruits and mainly grown in middle east, India, southern Asia and Mediterranean Europe, as well as in warm climate areas of the world including Americas [20]. It is a rich source of polyphenolic compounds like anthocyanidins (delphinidin, cyanidin and pelargonidin) and hydrolysable tannins (such as punicalagin, pedunculagin, punicalin, gallagic, ellagic acid esters of glucose) [21] against a variety of diseases including cancer [22], cardiovascular disorders [23], diabetes [24], Alzheimer's disease [25], aging [26], and AIDS [27]. Recently, it was shown to prevent development of non-alcoholic fatty liver disease in rats [28] and ethanol-induced toxicity in HepG2 human hepatoma cells [29]. Acute and sub-chronic toxicity studies with rodents revealed that oral administration of its extracts for up to ~ 4330 mg/kg/day is considered safe with no observable adverse effects [30], [31], [32]. Based on our recent results on alcohol-induced gut leakiness [18], [19], we hypothesized that POM, with various antioxidants and anti-inflammatory ingredients, can also prevent alcohol-mediated oxidative stress critically important in promoting gut leakiness and inflammatory liver injury. In this present study, we have evaluated the beneficial effects of POM on alcohol-induced gut leakiness and inflammatory liver injury in rats and investigated the protective mechanisms in rats as well as cultured hepatocytes and T84 colonic cells. 2 Material and methods 2.1 Materials All chemicals, urolithin A (UA) and ellagic acid (EA) used in this study were from Sigma Chemical (St. Louis, MO, USA). POM extracts (Bulk Supplements; 40% EA) were obtained from Amazon. T84 human colonic cell line (CCL-248) and AML12 normal mouse liver cells (CRL-2254) were purchased from the ATCC (American Type Culture Cells, Manassas, VA). Other materials not described here were the highest grades available and/or the same, as recently described [19], [33], [34]. 2.2 Animal treatments All animal experimental procedures were carried out by following the National Institutes of Health (NIH) guidelines for small animal experiments and approved by the NIAAA Institutional Animal Care and Use Committee. All rats were maintained under controlled lighting (12-h light/dark cycle) with food and water provided ad libitum. Age-matched 7-weeks old female Fischer 344 wild-type (WT) rats were orally administered a daily dose of 600 mg POM/kg, based on the safety and effective dosages of POM extracts [30], [31], [32], [35], [36]. Control rats were orally administrated a vehicle (water). After POM pretreatment for 10 days, some rats (n ≥ 4/group) were exposed to 3 oral doses of binge alcohol (5 g/kg/dose) or dextrose (as control) at 12-h intervals and euthanized 1-h after the last ethanol dose. 2.3 Culture of liver cells and colon cells The AML12 liver cells were cultured in DMEM/F-12 medium supplemented with 10% fetal bovine serum (FBS), 1% antibiotic-antimycotic solution, 0.1 μM dexamethasone, and insulin-transferrin-selenium (Invitrogen). Cells were grown at 37 °C under 5% CO2. AML12 cells were treated with 100 mM ethanol in the absence or presence of the selective inhibitor of UA (15 μM), EA (100 μM), or chlormethiazole (CMZ, 15 μM) for 24 h. T84 colon cells were grown in a humidified incubator under 95% air and 5% CO2 at 37 °C in Ham's F-12 medium, supplemented with 10% FBS, 1% antibiotic-antimycotic solution. Confluent monolayers appeared 6–14 day after plating. T84 monolayer cells were exposed to 40 mM ethanol in the absence or presence of the selective inhibitor of UA (15 μM), EA (100 μM), or CMZ (15 μM) for 8 h prior to harvest for subsequent analyses. 2.4 Histological analysis and serum ALT measurement Rats were briefly sedated to carbon dioxide gas followed by decapitation and immediate collection of trunk blood, small intestine, and liver from each rat. In this study, part of the largest liver lobe or small intestine from each rat exposed to POM pretreatment or control with or without binge ethanol exposure was fixed in neutral formalin. Paraffin-embedded blocks of formalin-fixed individual liver or small intestine sections were cut at 4 µm, stained with hematoxylin/eosin (H/E) by American Histolabs, Inc. (Gaithersburg, MD). To further support fat accumulation, frozen liver samples embedded in optimal cutting temperature compound were cut (10 µm) and stained with Oil Red O by American HistoLabs, Inc. The plasma ALT level in each rat was determined by using the standard end-point colorimetric assay kit (TECO Diagnostics, Anaheim, CA), as described [34]. 2.5 Endotoxin assay Plasma endotoxin levels were determined using the commercially available endpoint LAL Chromogenic Endotoxin Quantitation Kit with a concentration range of 0.015–1.2 EU/mL (Thermo Fisher Scientific, Waltham, MA), as described [19]. 2.6 Triglyceride determination in liver The amounts of hepatic triglyceride (TG) were assessed by using a commercially available kit (Thermo Fisher Scientific) [19], [34]. 2.7 Determination of the levels of hydrogen peroxide, nitrate/nitrite, lipid peroxidation and superoxide dismutase (SOD) activity in liver extracts The levels of hepatic hydrogen peroxide, nitrate/nitrite, lipid peroxidation and superoxide dismutase (SOD) activity were assessed by using commercially available kits, respectively (Cayman; Abcam; Oxford Biomedical Research; Cayman). 2.8 Determination of plasma ROS levels The amounts of plasma ROS were determined by visualization with 2′,7′-dichlorofluorescein diacetate (DCFH-DA, Thermo Fisher Scientific). Following incubation with DCFH-DA at 37 °C for 20 min, the DCFH-DA fluorescence was then determined by the method, as recently described [33]. 2.9 CYP2E1 activity assay CYP2E1 activities in the liver homogenates were measured, as described previously [34]. 2.10 Enzyme-linked immunosorbent assay (ELISA) The liver lysates prepared from individual POM-pretreated or control rats in the absence or presence of binge ethanol exposure were analyzed by using the respective ELISA kit for TNF-α or MCP-1 (Abcam, Cambridge, United Kingdom) by following the manufacturers' protocols. The protein concentration was measured with the BCA reagent (BioRad, Hercules, CA) to use the equal amounts of protein for the ELISA. Duplicate samples from each lysate (n = 4/group) were used for ELISA, which was repeated twice. 2.11 Immunoblot analysis and immunoprecipitation Parts of liver tissue and small intestine from each rat were homogenized with RIPA buffer. Same amounts (50 µg protein equally pooled from different rat samples within the same group) were separated by SDS/PAGE and transferred to nitrocellulose membranes. These membranes were incubated with the respective rabbit polyclonal antibody against CYP2E1 (1:5000 dilution; Abcam), p-JNK (1:1000 dilution; Cell Signaling), 3-NT (1:5000 dilution; Abcam), iNOS (1:5000 dilution; Abcam), P-PERK (1:1000 dilution; Santa Cruz Biotechnology), p-eIF2α (1:1000 dilution; Santa Cruz Biotechnology), PDI (1:1000 dilution; Santa Cruz Biotechnology), cleaved caspase-3 (1:1000 dilution; Cell Signaling), ZO-1 (1:5000 dilution; Abcam), claudin-1 (1:1000 dilution; Thermo Fisher), claduin-4 (1:1000 dilution; Thermo Fisher), or occludin (1:5000 dilution; Abcam). Respective mouse monoclonal antibody against JNK (1:1000 dilution; Cell Signaling), Bax (1:1000 dilution; Santa Cruz Biotechnology), β-catenin (1:1000 dilution; Santa Cruz Biotechnology), E-cadherin (1:1000 dilution; Santa Cruz Biotechnology), Plakoglobin (1:1000 dilution; Santa Cruz Biotechnology), α-tubulin (1:1000 dilution; Santa Cruz Biotechnology), ubiquitin (1:1000 dilution; Cell Signaling), or β-actin (1:10,000 dilution; Santa Cruz Biotechnology) was also used to detect the specific antigen target, as indicated. After washing the nitrocellulose membranes with PBS three times at 10 min intervals, horseradish peroxidase (HRP)-conjugated anti-rabbit or anti-mouse IgG (Santa Cruz Biotechnology) was used as the secondary antibody at 1:5000 dilution. Relative protein images were determined by using HRP-conjugated secondary antibodies and ECL substrates (Thermo Fishers). The intensities of the immuno-reactive bands were quantified by densitometry using ImageJ software (National Institutes of Health). Immunoprecipitation of small intestinal proteins was carried out, as described previously [19], [34]. Briefly, 0.5 mg proteins of small intestinal proteins equally pooled from individual control rats or POM-pretreated groups with or without ethanol exposure were incubated with the specific antibody to claudin-1 protein followed by addition of protein A/G-Sepharose for 4 h at 4 °C with constant head-to-tail rotations. Sepharose beads were pre-blocked with 2% BSA in PBS before being used for immunoprecipitation. After incubation, proteins bound to Sepharose beads were washed twice with the lysis buffer, four times with ice-cold PBS and mixed with 2x SDS-PAGE gel loading buffer. The immunoprecipitated proteins were resolved by SDS-PAGE for subsequent immunoblot analyses using the antibody to each target protein, as indicated in the actual figure. 2.12 Immunofluorescence and confocal microscopy For detecting CYP2E1 and ZO-1 by immunofluorescence, AML12 liver and T84 colonic cells were initially plated onto chamber slides, as described previously [19]. Briefly, the cells were fixed for 30 min at room temperature with 4% paraformaldehyde. After removal of the blocking solution, the cells were incubated with the specific antibody, as indicated, at 4 °C overnight. Anti-CYP2E1 or Anti-ZO-1 antibody was used at 1:300 dilution. For immunofluorescence detection, the cells were incubated with Alexa Fluor 488-labeled anti-rabbit secondary antibody (Thermo Fisher Scientific). For nuclear staining, the cells were counter-stained with 1 mg/mL 4′,6′-diamino-2-phenylindole (DAPI) for 5 min. The cells were washed and fixed with VECTASHIELD mounting solution (Vector Laboratories, Burlingame, CA). Fluorescence images were collected by using a confocal microscope (Carl Zeiss, Oberkochen, Germany). 2.13 TUNEL assay Small intestine and liver specimens were fixed overnight in 10% buffered formalin and embedded in paraffin. The ApopTag peroxidase in situ apoptosis detection kit (Millipore, Billerica, MA) was used to identify apoptotic enterocytes or hepatocytes by the TUNEL analysis, as recently described [19]. 2.14 RNA extraction and real-time analysis Total RNA was extracted from the individual rat livers using Trizol (Thermo Fisher Scientific), with overnight precipitation at 20 °C to increase the yield of RNA. For real-time analysis, cDNA was transcribed from a total of 600 ng of DNase I–treated RNA using the cDNA reverse-transcription kit and random primers (Thermo). Real-time quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) was performed using a Mx3000p System. To determine relative mRNA expression, housekeeping gene (β-actin) and apoptosis marker gene with SYBR green I (SYBR Advantage qPCR Premix) were used. 2.15 Trans-epithelial electrical resistance and FITC-D4 permeability analysis Colonic T84 cells were grown in transwell inserts with a surface area of 0.33 cm2 and 0.4 µm pore size (Thermo Fisher Scientific), as recently described [19]. The rates of trans-epithelial electrical resistance (TEER) of monolayer cells were measured with an epithelial volt-ohm-meter in each insert and multiplied by the membrane surface area (0.33 cm2), corrected by subtracting background resistance of the blank membrane (i.e., no cells). Data were collected from triplicates inserts per treatment in two independent experiments and expressed as percentage of basal TEER (i.e., 600 Ω cm2) obtained before treatment. At the end of TEER measurements, FITC-labeled 4-kDa dextran (1 mg/mL FITC-D4; Sigma) was added to the apical side of cells. Monolayer permeability was assessed by measuring the fluorescence of FITC-D4 in the basal medium compartment spectrophotometrically using a microplate reader at excitation and emission spectra of 485 and 540 nm, respectively. Data were reported as relative fluorescent units (% baseline). 2.16 Statistical analysis and other methods Statistical significance was determined using one-way ANOVA and Dunnet's multiple comparison post-tests were used to compare the means of different groups. All the experiments were repeated at least twice unless otherwise stated. Data were presented as mean ± SD. Different letters in actual figures stand for significant difference between various treatments at p < 0.05 by one-way ANOVA. GraphPad Prism 7.0 (GraphPad Software Inc., La Jolla, CA) was used for analysis. Other methods not described in this study were the same as recently reported [19], [33], [34]. 3 Results 3.1 Pomegranate decreased the alcohol-mediated hepatic fat accumulation, plasma ALT, and hepatic triglyceride levels Based on the safety data [30], [31], [32] and previous reports by other scientists [35], [36], rats were treated with oral gavages of POM (600 mg/kg/day) to determine its protective effects against alcoholic fatty liver. Our results showed that there was no significant difference in the initial mean body weights of rats among the different groups (i.e., no change in body weight gains among different groups, data not shown). Histological analyses with H/E and oil red O staining showed slightly but significantly elevated fat accumulation in the liver after binge alcohol-exposure compared to that of dextrose-control (Fig. 1A and B, respectively). In contrast, POM pretreatment reduced the hepatic lipid droplets elevated after binge alcohol-exposure (Fig. 1A and B). The liver H/E-stained histology data are consistent with the significant changes in the levels of hepatic triglyceride (TG) (Fig. 1C) and plasma ALT (Fig. 1D), where whereas POM pretreatment decreased these increments. However, POM pretreatment did not significantly reduce the elevated BAC at 1 h after the last oral ethanol administration (Fig. 1E). These results suggest that the effects of POM are likely resulted from modulating other factors but not by affecting the BAC.Fig. 1 POM prevented binge alcohol-induced fatty liver and injury in rats. (A and B) Representative H/E or Oil Red O staining of formalin-fixed or frozen liver sections for control (CON), pomegranate (POM), ethanol (EtOH), or POM+EtOH-exposed rats. Inset within each figure represents a higher magnification image. The levels of (C) hepatic triglyceride (TG), (D) plasma ALT, and (E) BAC. Data represent means ± SD. Different letters stand for significant difference between various treatments at p < 0.05 by one-way ANOVA. Labeled characters without a common letter represent significant differences from the other group(s). Fig. 1 3.2 Pomegranate decreased the hepatic oxidative stress, ER stress, and apoptosis marker proteins in binge alcohol-exposed rats The CYP2E1 is one of the major contributors in alcohol-induced oxidant stress, contributing to alcohol-induced liver injury [9], [12], [13], [18]. Our data showed that the levels of hepatic CYP2E1 protein expression and activity were significantly increased in alcohol-exposed rats (Fig. 2A and Supplemental Fig. 1). In contrast, POM reduced the alcohol-mediated increase in the levels of CYP2E1 protein expression and activity. In addition, the elevated amounts of inducible nitric oxide synthase (iNOS) protein following alcohol exposure were significantly decreased in POM-pretreated rats (Fig. 2A). The elevated amounts of nitrated proteins reflected by 3-NT immunoreactivity were significantly decreased in POM-pretreated rats compared to the corresponding alcohol-exposed rats (Fig. 2A). The increased amounts of hepatic hydrogen peroxide and nitrate/nitrite were significantly decreased in POM-pretreated rats compared to the corresponding alcohol-exposed rats (Supplemental Fig. 2A and B). Additionally, the decreased hepatic superoxide dismutase (SOD) activities in alcohol-exposed rats were restored in POM-pretreated rats (Supplemental Fig. 2C).Fig. 2 POM prevented hepatic oxidative stress, ER stress, and apoptosis marker proteins in binge alcohol-exposed rats. (A) The levels of hepatic CYP2E1, iNOS, and nitrated proteins detected by anti-3-NT antibody, (B) liver ER stress marker proteins p-PERK, p-eIF2α, and PDI, (C) liver apoptosis marker proteins p-JNK, Bax, and cleaved-caspase-3 and (D) TUNEL analyses in the indicated groups are presented. The arrows represent TUNEL positive cells. Densitometric quantitation of each immunoreactive protein relative to β-actin, used as a loading control, is shown. Data represent means ± SD. Significant difference between various treatments was determined by one-way ANOVA. Labeled characters without a common letter represent significant differences from the other group(s). Fig. 2 CYP2E1 induction or activation is usually associated with increased production of reactive oxygen species (ROS). Elevated ROS production is likely to increase lipid peroxidation products. Our results showed that the elevated levels of plasma ROS and lipid peroxidation (MDA+HNE) in alcohol-exposed rats were significantly decreased in POM-pretreated rats (Supplemental Fig. 3). To determine whether POM-mediated prevention of alcohol-induced hepatic injury is promoted through decreased ER stress, we evaluated the hepatic levels of ER stress markers such as phospho-protein kinase-like endoplasmic reticulum kinase (PERK), phospho-eukaryotic translation initiation factor-2α (eIF2α), and protein disulfide isomerase (PDI). Alcohol-exposure increased the levels of hepatic p-PERK, p-eIF2α, and PDI. POM pre-treatment significantly attenuated ER stress as indicated by the significant reduction of the increased amounts of p-PERK, p-eIF2α, and PDI in alcohol-exposed rats (Fig. 2B). To further test whether POM-mediated prevention of alcohol-induced hepatic injury is promoted through decreased levels of hepatic apoptosis, we determined the expression of apoptosis-related protein markers. We observed that binge alcohol increased the amounts of hepatic p-JNK, Bax, and cleaved caspase-3 proteins and that POM pretreatment significantly decreased the alcohol-mediated increments of these proteins (Fig. 2C). Furthermore, TUNEL analyses followed by quantitation revealed that ethanol-exposure significantly increased apoptosis of hepatocytes while this elevation was markedly reduced by POM pretreatment (Fig. 2D). Taken together, these results revealed that POM significantly attenuated oxidative/nitrative stress, ER stress, and hepatic apoptosis in alcohol-exposed rats. 3.3 Pomegranate decreased the hepatic inflammation response in binge alcohol-exposed rats Binge alcohol consumption can stimulate gut leakiness, contributing to increased hepatic steatosis and inflammation [18], [19]. Therefore, we evaluated the levels of inflammation marker proteins. ELISA analysis showed that alcohol exposure elevated the hepatic contents of TNF-α and MCP-1, both of which were significantly decreased by POM-pretreatment (Fig. 3A and B). In addition, immunoblot analysis showed that hepatic levels of inflammation-associated proteins TLR-4, TNF-α, IL-1β and MCP-1 were significantly elevated in alcohol-induced liver injury but decreased in POM-pretreated rats (Fig. 3C). These results indicated that POM significantly decreased the expression of hepatic inflammation-associated cytokine/chemokine in alcohol-exposed rats.Fig. 3 POM prevented increased hepatic inflammation marker proteins in binge alcohol exposed rats. (A and B) ELISA results for TNF-α and MCP-1 in the liver lysates from control (CON), pomegranate (POM), ethanol (EtOH), or POM+EtOH-exposed rats are presented. (C) The levels of hepatic TLR4 and inflammation-associated proteins (TNF-α, IL-1β, and MCP-1) in the indicated groups are presented. Significant difference between various treatments was determined by one-way ANOVA. Labeled characters without a common letter represent significant differences from the other group(s). Fig. 3 3.4 Urolithin A and ellagic acid decreased the oxidative stress and inflammation related genes in AML12 liver cells EA and UA are natural polyphenols contained in POM with antiproliferative and antioxidant properties [20], [21], [22], [23], [24], [25], [26], [27], [28], [29]. Based on the prevention of alcohol-induced liver injury by POM (Fig. 1, Fig. 2, Fig. 3), we further studied the mechanisms of the beneficial effects by its individual components UA and EA on oxidative stress and inflammation-related mRNAs upregulated after binge alcohol exposure. Based on the previous studies with UA [37] and EA [38], AML12 normal liver cells were treated with 100 mM ethanol in the absence or presence of UA, EA, or CMZ for 24 h. Confocal microscopy image showed that binge alcohol significantly increased the CYP2E1 expression. However, pretreatment with UA or EA at the indicated concentration decreased the CYP2E1 expression in ethanol-exposed AML12 cells, as comparable to that treated with CMZ, a specific inhibitor of CYP2E1 transcription (Fig. 4A). Immunoblot analysis demonstrated that pretreatment with UA or EA significantly decreased the amounts of CYP2E1, iNOS, and nitrated proteins in alcohol-exposed AML12 liver cells (Fig. 4B). Furthermore, real-time RT-PCR analysis revealed that UA or EA pretreatment significantly suppressed the elevated mRNA levels of inflammation markers NLRP3, IL-1β, and TNF-α in alcohol-exposed AML12 cells (Fig. 4C).Fig. 4 Urolithin A and Ellagic acid suppressed the CYP2E1 amount, oxidative stress and inflammation maker proteins in alcohol-exposed AML12 liver cells. AML12 liver cells were treated with culture media (CON) or 100 mM ethanol (EtOH) in the absence or presence of 15 µM Urolithin A (UA), 100 µM Ellagic acid (EA), or 15 µM chlormethiazole (CMZ) for 24 h, as indicated. (A) Confocal image showing the reduction of CYP2E1 in ethanol-exposed AML12 cells with or without UA, EA, or the CYP2E1 inhibitor CMZ. Cell nuclei were counter-stained with DAPI. (B) Immunoblot analyses for CYP2E1, iNOS, and nitrated proteins detected by anti-3-NT antibody in AML12 cell lysates for the indicated groups. Densitometric quantitation of the immunoblots for each protein, relative to the loading control β-actin, is shown where each lane represents the protein samples equally combined from 2 specimens within the same groups (n = 4/group). (C) The levels of mRNA transcripts for NLRP3, IL-1β, and TNF-α in the indicated groups are presented (n = 4/group). Significant difference between various treatments was determined by one-way ANOVA. Labeled characters without a common letter represent significant differences from the other group(s). Fig. 4 3.5 Pomegranate decreased the plasma endotoxin and intestinal TNF-α protein in binge alcohol-exposed rats Since hepatic inflammation could be indirectly stimulated by increased leaky gut and endotoxemia [4], [5], [6], [7], the levels of plasma endotoxin and intestinal TNF-α were measured to determine whether the POM-mediated prevention of alcoholic liver injury could result from the inhibition of endotoxemia. H/E stained histology slides revealed disorganization and detachment of many intestinal epithelial cells with abnormal shapes in alcohol-exposed rats compared to those of dextrose-controls (Fig. 5A). POM pretreatment prevented these abnormal shapes and restored their contours. Morphometric analysis of H/E stained sections showed that alcohol-exposed rats had significantly shorter villus height compared to control rats (Fig. 5B). Consistently, binge alcohol exposure markedly elevated the plasma endotoxin concentration compared to the control rats, whereas POM pretreatment significantly prevented this increase (Fig. 5C). Additionally, elevated levels of intestinal TNF-α and MCP-1 in alcohol-exposed rats were significantly decreased by POM pretreatment (Fig. 5D and E).Fig. 5 POM prevented binge alcohol-mediated gut damage, endotoxemia, and intestinal TNF-α and MCP-1 production in rats. (A) Representative histology slides of rat small intestines stained with H/E, (B) villus height (μm), (C) the levels of plasma endotoxin, (D) TNF-α and (E) MCP-1 in the intestinal lysates from the indicated groups are presented. Significant difference between various treatments was determined by one-way ANOVA. Labeled characters without a common letter represent significant differences from the other group(s). Fig. 5 3.6 Pomegranate reduced the intestinal oxidative stress, nitration, acetylation, and ubiquitination in binge alcohol-exposed rats Increased nitroxidative stress with elevated levels of CYP2E1, iNOS and nitrated proteins are the major factors in alcohol-mediated intestinal barrier dysfunction [18], [19]. Binge alcohol markedly elevated the amounts of intestinal CYP2E1 and iNOS whereas POM pretreatment significantly prevented the increments by binge alcohol (Fig. 6A).Fig. 6 POM prevented elevated oxidative stress and protein nitration, acetylation, and ubiquitination of intestinal proteins in binge alcohol-exposed rats. (A) Intestinal CYP2E1 and iNOS in the indicated groups are presented. Densitometric quantitation of each immunoreactive protein, relative to β-actin, is shown. (B–D) Intestinal nitrated proteins detected by anti-3-NT antibody, acetylated protein, and ubiquitin-conjugated proteins in the indicated groups are presented. Significant difference between various treatments was determined by one-way ANOVA. Labeled characters without a common letter represent significant differences from the other group(s). Fig. 6 Alcohol exposure was recently shown to promote post-translational protein modifications (PTMs) including methylation, nitration, phosphorylation, and acetylation [8], [10]. Immunoblot results showed that binge alcohol markedly elevated the intestinal protein nitration, lysine acetylation and ubiquitin-conjugated proteins. In contrast, POM pretreatment significantly inhibited the alcohol-mediated increments of these modified proteins (Fig. 6B–D). Therefore, POM pretreatment prevented alcohol-mediated gut leakiness by at least partially suppressing the CYP2E1, iNOS, elevated nitration, acetylation, and ubiquitination-conjugation of many intestinal proteins in alcohol-exposed rats. 3.7 Pomegranate restored the altered levels of intestinal tight junctions, adherent junctions, and apoptosis marker proteins in binge alcohol-exposed rats Gut leakiness and endotoxemia can be resulted from decreased intestinal tight junction (TJ) and adherent junction (AJ) proteins and elevated apoptosis of intestinal enterocytes [19]. Therefore, the levels of intestinal epithelial TJ and AJ were examined to study the underlying mechanisms by which POM prevents the gut barrier dysfunction. Binge alcohol exposure significantly decreased the levels of a few typical TJ proteins ZO-1, occludin, claudin-1, and claudin-3 (Fig. 7A). However, POM significantly restored the basal levels of these TJ proteins markedly suppressed in alcohol-exposed rats (Fig. 7A). Similarly, binge alcohol exposure significantly decreased the levels of AJ proteins β-catenin, E-cadherin, plakoglobin, and α-tubulin whereas POM pretreatment prevented these decrements and restored their normal levels comparable to those of dextrose-controls (Fig. 7B).Fig. 7 POM prevented the changes in gut TJ/AJ proteins and apoptosis marker proteins in binge alcohol-exposed rats. Representative levels of (A) gut TJ proteins ZO-1, claudin-1, claudin-3, and occludin, (B) AJ proteins (β-catenin and E-cadherin), plakoglobin and α-tubulin, (C) nitrated or ubiquitin-conjugated proteins, (D) apoptosis marker proteins p-JNK, Bax, and cleaved caspase-3, and (E) TUNEL analyses in the indicated groups are shown. The arrows indicate TUNEL positive cells. Densitometric quantitation of the immunoblots for each protein relative to β-actin is shown. (C) The same amounts of intestinal proteins equally combined from 4 rats/group were immunoprecipitated with the specific antibody to claudin-1 and then subjected to immunoblot analysis with the specific antibody to 3-NT (top panel) and ubiquitin (bottom). Significant difference between various treatments was determined by one-way ANOVA. Labeled characters without a common letter represent significant differences from the other group(s). Fig. 7 To further investigate the mechanisms for the decreased TJ and/or AJ proteins in alcohol-exposed rats, we performed immunoprecipitation (IP) followed by immunoblot (IB) analysis. Our IP and IB analysis showed that nitration of claudin-1, used as an example of TJ protein, was significantly elevated in binge alcohol-exposed rats (Fig. 7C). In addition, the amounts of ubiquitin-conjugated protein were increased in immunoprecipitated claudin-1, suggesting its decreased levels through proteolytic degradation in binge alcohol-exposed rats. However, POM pretreatment reduced the amounts of nitrated and ubiquitin-conjugated claudin-1, resulting in the restoration of its level and prevention of the leaky gut in alcohol-exposed rats. To further study the preventive mechanism of POM against alcohol-mediated gut leakiness, we also determined the levels of apoptosis-associated proteins such as p-JNK, Bax and cleaved (activated) caspase-3 in different rat intestines as indicated. Immunoblot results showed binge alcohol exposure significantly increased these apoptosis marker proteins, whereas POM pretreatment prevented their increments in alcohol-exposed rat intestines (Fig. 7D). In addition, TUNEL analyses followed by quantitation (not shown) showed significantly elevated apoptosis of intestinal enterocytes in alcohol-exposed rats compared to that of dextrose-control, whereas this elevation was markedly reduced by POM pretreatment (Fig. 7E). These results demonstrate that POM restored intestinal TJ and AJ proteins while decreasing apoptosis of enterocytes, contributing to prevention of alcohol-induced gut leakiness. To support our in vivo animal data, epithelial cell permeability of T84 colonic cells and the underlying mechanisms were evaluated in the absence or presence of 40 mM ethanol exposure with or without UA, EA, or CMZ for 8 h. Confocal image analysis showed that alcohol exposure disrupted the normal distribution of ZO-1, used as an example of TJ protein (Fig. 8A) while it decreased viability of T84 colon cells (Fig. 8B). However, the alcohol-mediated changes in confocal image and cell viability were significantly prevented by treatment with UA, EA, or CMZ (Fig. 8B). Furthermore, binge alcohol exposure significantly decreased the rates of TEER (Fig. 8C) with elevated permeation of FITC-D4 (Fig. 8D). However, co-treatment with UA, EA, or CMZ significantly blocked abnormal changes of ZO-1 TJ protein, viability and epithelial cell permeability in alcohol-exposed T84 colon cells (Fig. 8). Confocal image analyses of immunoreactive CYP2E1 revealed that UA, EA, or CMZ treatment reduced the elevated levels of CYP2E1 following ethanol exposure (Supplemental Fig. 4). These in vitro results are consistent with the in vivo rat results and further support the important roles of CYP2E1 and oxidative stress in promoting epithelial barrier dysfunction following alcohol-exposure.Fig. 8 Urolithin A and Ellagic acid prevented epithelial cell barrier dysfunction in alcohol-exposed T84 colon cells. T84 cells were treated with culture media (CON) or 40 mM ethanol (EtOH) in the absence or presence of 15 µM UA, 100 µM EA, or 15 µM CMZ for 8 h, as indicated. (A) Confocal image showing the disorganized ZO-1 in ethanol-exposed T84 cells but restored ZO-1 after treatment with UA, EA, or the CYP2E1 inhibitor CMZ. Cell nuclei were counter-stained with DAPI. (B) Cell viability of the indicated groups is also presented. (C–D) Representative levels of TEER (C) and permeability to FITC-D4 after 3 h pretreatment without or with the specific agent, UA, EA, or CMZ. Data indicate means ± SD of triplicate wells from two separate experiments. Significant difference between various treatments was determined by one-way ANOVA. Labeled characters without a common letter represent significant differences from the other group(s). Fig. 8 4 Discussion It is well-established that chronic and/or excessive amounts of binge alcohol intake can damage many cells or organs. One of the main causes of alcohol-induced organ damage is the elevated oxidative and nitrative (nitroxidative) stress through activating pro-oxidant enzymes/genes while suppressing the antioxidant levels including glutathione [39], [40]. Some of the pro-oxidant enzymes induced or activated after alcohol exposure are CYP2E1 and iNOS, which are responsible for production of reactive oxygen and nitrogen species, respectively, contributing to elevated nitroxidative stress [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19]. In fact, alcohol-induced CYP2E1 protein expression has been directly linked to the development of both steatosis and inflammation [2], [9], [15]. For instance, Cyp2e1-KO or iNOS-KO mice were resistant to alcohol-induced liver injury [39], [41] and non-alcoholic substance such as n-6 fatty acid containing western-style high fat diets [14]. In contrast, transgenic mice with over-expressed CYP2E1 [42], or Cyp2e1-KI mice [43] were sensitive to tissue damage to alcohol [12] or non-alcoholic substances [44], [45]. CYP2E1 and iNOS are also expressed in the intestine and upregulated by chronic [17] and binge alcohol exposure [18], [19], [46]. Subsequently, increased nitroxidative stress, produced from elevated CYP2E1 and iNOS, can increase PTMs such as oxidation, nitration, phosphorylation, acetylation, adduct formation, etc. of hepatic and intestinal proteins, as reported [40], [47], [48], [49], [50], [51], contributing to mitochondrial dysfunction, ER stress, and cell/tissue injury. It is well-established that increased ER stress is an important causal factor in alcoholic (ALD) and non-alcoholic fatty liver disease (NAFLD) [52], [53], [54], [55]. Further, ER stress is closed associated with activation of the apoptotic pathways after failure to adapt to ER stress [56]. Consistent with these reports, our current results showed that binge alcohol significantly increased the hepatic levels of ER stress marker proteins such as p-PERK, p-eIF2α, and PDI, with increased levels of apoptosis marker proteins including p-JNK, Bax, and cleaved caspase-3. In addition, the hepatic levels of inflammatory cytokines TNF-α and IL-1β as well as chemokine MCP-1 were significantly elevated in alcohol-exposed rats compared to those of dextrose-control. These results demonstrate that significantly increased hepatic ER stress, inflammatory cytokines/chemokines and apoptosis of hepatocytes played important roles in promoting inflammatory hepatic injury in alcohol-exposed rats. In addition to direct insults to the liver, excessive amounts of alcohol can indirectly stimulate hepatic damage by activating the leaky gut and endotoxemia via the gut-liver axis [4], [5], [6], [7]. Epithelial TJ and AJ proteins confer the epithelial mucosal barrier function in the intestine and other tissues. For instance, the junctional complex proteins represent multi-protein complexes consisting of transmembrane proteins such as junctional adhesion molecules and adapter proteins which interact with many other proteins including actin-binding proteins [57]. Recent reports showed the contributing roles of increased gut leakiness and endotoxemia in promoting inflammatory injury in many tissues or disease states including alcoholic and non-alcoholic fatty liver disease with inflammation [4], [5], [6], [7], [58], [59]. In addition, elevated gut leakiness and endotoxemia are implicated in many other diseases or potentially toxic conditions, such as burn injury [60], radiation [61], autism [62], and Gulf War illness [63], although the underlying mechanisms of each disease state are not fully understood. Many different mechanisms of alcohol-induced gut leakiness and inflammatory liver injury have been proposed. One of the leading mechanisms of alcohol-induced intestinal barrier dysfunction is the altered composition of gut microbiome (enteric dysbiosis) with decreased abundance of Bacteroidetes and Firmicutes phyla with proportionally elevated levels of the gram negative Proteobacteria and gram positive Actinobacteria phyla [64], [65], [66], [67] while pomegranate intake can alter gut microbiota with elevated growth of probiotic bacteria and increased production of short chain fatty acids, including propionate and butyrate [68], [69]. However, it is still poorly understood how different gut bacterial composition or dysbiosis stimulates leaky gut on molecular levels. Our recent data showed that elevated apoptosis of enterocytes and nitration of the junctional complex proteins contributed to alcohol-induced gut leakiness in rats, mice and humans [19]. In this case, the levels of CYP2E1, iNOS and nitrated proteins were elevated and contributed to increased gut barrier dysfunction in alcohol-exposed rodents whereas pretreatment with a general anti-oxidant or the specific inhibitor of CYP2E1 or iNOS significantly prevented alcohol-induced gut leakiness. Furthermore, Cyp2e1-null mice were quite resistant to alcohol-induced gut leakiness and inflammatory liver injury despite the exposure to extremely high dosages of alcohol (3 consecutive doses of 6 g/kg/dose at 12-h intervals), demonstrating the critical roles of CYP2E1 and oxidative stress in alcohol-mediated gut leakiness. These results are consistent with the many direct and indirect roles of CYP2E1, which was shown to be involved in oxidative stress and various PTMs including protein nitration [40], [47], [70], [71]. POM contains many polyphenols and anti-oxidants, including EA and UA. Therefore, POM extracts and/or juice have been widely used in alleviating or preventing various conditions of many disease models as a safe dietary supplement [72], [73], [74]. However, its preventive effects on alcohol-induced gut leakiness and inflammatory liver injury are relatively unknown, although POM juice also exhibited protective effects against hepatic oxidative stress in mice [75] possibly through suppression of CYP2E1 by EA [35]. Several reports also showed that POM extract or juice attenuated inflammatory conditions through inhibition of proinflammatory cytokines and chemokines [28], [76], [77], [78], [79]. Based on our recent results about the causal roles of CYP2E1 and nitroxidative stress in alcohol-induced gut leakiness [18], [19] and the anti-oxidant properties of POM, we studied the protective effects of POM against alcohol-induced gut leakiness and liver inflammation. We also elucidated the underlying mechanisms of POM-mediated protection against alcohol-induced gut and liver injury. In the current study, we provided direct in vivo and in vitro evidence that POM protected the alcohol-induced gut leakiness and inflammatory liver injury through suppressing the nitroxidative stress with elevated levels of CYP2E1, iNOS and nitrated proteins in the intestines and livers of the alcohol-exposed rats. Our data revealed that binge alcohol increased hepatic injury, fat accumulation, nitroxidative stress, nitrated proteins, ER stress and apoptosis marker proteins as well as inflammation response in the liver. Under these conditions, POM pretreatment significantly prevented changes in all these parameters with efficient blockade of gut leakiness and hepatic injury in alcohol-exposed rats (Fig. 9). In addition, pretreatment with an individual compound of POM EA or UA significantly reduced the elevated levels of CYP2E1, iNOS and nitrated proteins as well as the mRNA transcripts of NLRP3, IL-1β, and TNF-α in alcohol-exposed AML12 liver cells. Therefore, these studies indicate that the beneficial effects of POM could result from suppressed inflammation in alcohol-exposed hepatocytes and rats. Consistently, POM pretreatment suppressed the plasma endotoxin and restored the decreased intestinal TJ and AJ proteins, leading to prevention of alcohol-induced gut leakiness (Fig. 9). Furthermore, we showed the preventive effects of EA and UA against disruption or decreased TJ protein claudin-1 or ZO-1 with altered TEER and FITC-D4 transport rates in alcohol-exposed T84 colon cells, although the beneficial effects of the individual polyphenols of POM need to be studied in in vivo models. Based on the previous results [18], [19], [46], we believe that decreased CYP2E1 in POM-pretreated rats could at least partly be an underlying mechanism by which POM prevented gut leakiness, endotoxemia and inflammatory liver injury. Alternatively, POM pretreatment may also improve the dysbiosis by decreasing the endotoxin producing bacteria, although this needs further characterization.Fig. 9 Summary of the preventive effects of pomegranate against alcohol-Induced oxidative stress, gut leakiness, endotoxemia and inflammatory fatty liver. The effects of alcohol (ethanol) are shown in red while the benefits of pomegranate are marked in green, as indicated. The up and down arrows indicate an increment and decrease of each indicated parameter, respectively (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.). Fig. 9 Our detailed mechanistic studies also demonstrated that the protection of the intestinal barrier dysfunction by POM pretreatment was achieved in part through suppression of elevated nitroxidative stress and subsequent PTMs with the restoration of the basal levels of intestinal TJ and AJ proteins that were markedly decreased after alcohol-exposure. First, POM pretreatment prevented the reduced amounts of gut TJ proteins such as ZO-1, occludin, claudin-1 and claudin-3 in alcohol-exposed rats. Second, POM pretreatment also prevented the decreased levels of AJ proteins like β-catenin, E-cadherin, plakoglobin, and α-tubulin. Third, POM pretreatment prevented apoptosis marker proteins such as p-JNK, Bax, and cleaved caspase-3 in intestinal enterocytes in alcohol-exposed rats. Confocal image analyses also demonstrated that POM component EA or UA decreased the levels of CYP2E1 and prevented disorganization of a ZO-1 TJ protein in T84 colon cells. Therefore, POM pretreatment may prevent the abnormal distribution of TJ and AJ proteins as well as the activation of apoptosis of enterocytes. Finally, IP followed by immunoblot analyses confirmed increased nitration and ubiquitin conjugation of claudin-1, indicating ubiquitin-dependent proteolytic degradation of this TJ protein in alcohol-exposed rat intestines, as we recently reported [18], [19], [46]. Although we did not further study the levels of nitration and ubiquitin-conjugation of many other TJ or AJ proteins [57], it is highly likely that other junctional complex proteins might undergo similar modifications, based on the decreased amounts of intestinal TJ or AJ proteins with elevated nitrated proteins in alcohol-exposed rats compared to those in dextrose controls, as similar to the recent report [57]. Therefore, POM pretreatment restored the basal levels of TJ/AJ proteins and prevented elevated apoptosis of enterocytes, contributing to protection against alcohol-induced gut leakiness, endotoxemia and inflammatory liver injury. In conclusion, our current results demonstrated for the first time, to our knowledge, that POM can reduce plasma endotoxin and protect against alcohol-induced gut leakiness and inflammatory liver injury. Our mechanistic studies further revealed that the elevated levels of CYP2E1, iNOS and nitrated proteins and ER stress along with hepatic apoptosis and inflammatory markers in alcohol-exposed rats were significantly decreased by POM pretreatment. In addition, POM pretreatment restored the basal levels of the intestinal junctional complex proteins and prevented apoptosis of enterocytes, leading to prevention of alcohol-mediated leaky gut and endotoxemia (Fig. 9). Histological and confocal imaging analyses showed that POM could restore the gut shapes by preventing the loss or disruption of various intestinal TJ/AJ proteins with normalization of colon epithelial cell barrier function and suppression of apoptosis of enterocytes in alcohol-exposed rats and T84 colon cells. These findings provide a potentially novel prevention or treatment of alcohol-induced gut leakiness and inflammatory liver injury by POM and/or its components. Appendix A Supplementary material Supplementary material Acknowledgements This research was supported by the Intramural Program of the National Institute on Alcohol Abuse and Alcoholism. This work was also supported by a grant (to YEC) from the KRIBB Research Initiative Program (Korean Biomedical Scientist Fellowship Program), Korea Research Institute of Bioscience and Biotechnology, Republic of Korea. Competing interests The authors declare no competing financial interests. Appendix A Supplementary data associated with this article can be found in the online version at doi:10.1016/j.redox.2018.07.012. ==== Refs References 1 Adachi M. Brenner D.A. Clinical syndromes of alcoholic liver disease Dig. Dis. 23 3–4 2005 255 263 16508290 2 Lu Y. Wu D. Wang X. Ward S.C. Cederbaum A.I. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice Free Radic. Biol. Med. 49 9 2010 1406 1416 20692331 3 Tilg H. Day C.P. Management strategies in alcoholic liver disease Nat. Clin. Pract. Gastroenterol. Hepatol. 4 1 2007 24 34 17203086 4 Keshavarzian A. Farhadi A. Forsyth C.B. Rangan J. Jakate S. Shaikh M. Banan A. Fields J.Z. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats J. Hepatol. 50 3 2009 538 547 19155080 5 Szabo G. Bala S. Alcoholic liver disease and the gut-liver axis World J. Gastroenterol. 16 11 2010 1321 1329 20238398 6 Wang H.J. Zakhari S. Jung M.K. Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development World J. Gastroenterol. 16 11 2010 1304 1313 20238396 7 Bode C. Kugler V. Bode J.C. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess J. Hepatol. 4 1 1987 8 14 3571935 8 Osna N.A. Carter W.G. Ganesan M. Kirpich I.A. McClain C.J. Petersen D.R. Shearn C.T. Tomasi M.L. Kharbanda K.K. Aberrant post-translational protein modifications in the pathogenesis of alcohol-induced liver injury World J. Gastroenterol. 22 27 2016 6192 6200 27468209 9 Cederbaum A.I. Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity Dig. Dis. 28 6 2010 802 811 21525766 10 Song B.J. Akbar M. Jo I. Hardwick J.P. Abdelmegeed M.A. Translational implications of the alcohol-metabolizing enzymes, including cytochrome P450-2E1, in alcoholic and nonalcoholic liver disease Adv. Pharmacol. 74 2015 303 372 26233911 11 Wang Y. Millonig G. Nair J. Patsenker E. Stickel F. Mueller S. Bartsch H. Seitz H.K. Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease Hepatology 50 2 2009 453 461 19489076 12 Morgan K. French S.W. Morgan T.R. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage Hepatology 36 1 2002 122 134 12085356 13 Wu D. Wang X. Zhou R. Cederbaum A. CYP2E1 enhances ethanol-induced lipid accumulation but impairs autophagy in HepG2 E47 cells Biochem. Biophys. Res. Commun. 402 1 2010 116 122 20932821 14 Abdelmegeed M.A. Banerjee A. Yoo S.H. Jang S. Gonzalez F.J. Song B.J. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis J. Hepatol. 57 4 2012 860 866 22668639 15 Abdelmegeed M.A. Choi Y. Ha S.K. Song B.J. Cytochrome P450-2E1 promotes aging-related hepatic steatosis, apoptosis and fibrosis through increased nitroxidative stress Free Radic. Biol. Med. 91 2016 188 202 26703967 16 Abdelmegeed M.A. Choi Y. Ha S.K. Song B.J. Cytochrome P450-2E1 is involved in aging-related kidney damage in mice through increased nitroxidative stress Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc. 109 Pt 1 2017 48 59 17 Roberts B.J. Shoaf S.E. Jeong K.S. Song B.J. Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 h or less Biochem. Biophys. Res. Commun. 205 2 1994 1064 1071 7802633 18 Abdelmegeed M.A. Banerjee A. Jang S. Yoo S.H. Yun J.W. Gonzalez F.J. Keshavarzian A. Song B.J. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis Free Radic. Biol. Med. 65 2013 1238 1245 24064383 19 Cho Y.E. Yu L.R. Abdelmegeed M.A. Yoo S.H. Song B.J. Apoptosis of enterocytes and nitration of junctional complex proteins promote alcohol-induced gut leakiness and liver injury J. Hepatol. 2018 20 Pagliarulo C. De Vito V. Picariello G. Colicchio R. Pastore G. Salvatore P. Volpe M.G. Inhibitory effect of pomegranate (Punica granatum L.) polyphenol extracts on the bacterial growth and survival of clinical isolates of pathogenic Staphylococcus aureus and Escherichia coli Food Chem. 190 2016 824 831 26213044 21 Lansky E.P. Newman R.A. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer J. Ethnopharmacol. 109 2 2007 177 206 17157465 22 Nunez-Sanchez M.A. Gonzalez-Sarrias A. Garcia-Villalba R. Monedero-Saiz T. Garcia-Talavera N.V. Gomez-Sanchez M.B. Sanchez-Alvarez C. Garcia-Albert A.M. Rodriguez-Gil F.J. Ruiz-Marin M. Pastor-Quirante F.A. Martinez-Diaz F. Tomas-Barberan F.A. Espin J.C. Garcia-Conesa M.T. Gene expression changes in colon tissues from colorectal cancer patients following the intake of an ellagitannin-containing pomegranate extract: a randomized clinical trial J. Nutr. Biochem. 42 2017 126 133 28183047 23 Delgado N.T. Rouver W.D. Freitas-Lima L.C. de Paula T.D. Duarte A. Silva J.F. Lemos V.S. Santos A.M. Mauad H. Santos R.L. Moyses M.R. Pomegranate extract enhances endothelium-dependent coronary relaxation in isolated perfused hearts from spontaneously hypertensive ovariectomized rats Front. Pharmacol. 7 2016 522 28101057 24 McFarlin B.K. Strohacker K.A. Kueht M.L. Pomegranate seed oil consumption during a period of high-fat feeding reduces weight gain and reduces type 2 diabetes risk in CD-1 mice Br. J. Nutr. 102 1 2009 54 59 19079947 25 Essa M.M. Subash S. Akbar M. Al-Adawi S. Guillemin G.J. Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer's disease PloS One 10 3 2015 e0120964 25807081 26 Lan Y. Wu J. Wang X. Sun X. Hackman R.M. Li Z. Feng X. Evaluation of antioxidant capacity and flavor profile change of pomegranate wine during fermentation and aging process Food Chem. 232 2017 777 787 28490140 27 Neurath A.R. Strick N. Li Y.Y. Debnath A.K. Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide BMC Infect. Dis. 4 2004 41 15485580 28 Noori M. Jafari B. Hekmatdoost A. Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation J. Sci. Food Agric. 97 8 2017 2327 2332 27717115 29 Wang Y. Qiu Z. Zhou B. Liu C. Ruan J. Yan Q. Liao J. Zhu F. In vitro antiproliferative and antioxidant effects of urolithin A, the colonic metabolite of ellagic acid, on hepatocellular carcinomas HepG2 cells Toxicol. in Vitro: Int. J. Publ. Assoc. BIBRA 29 5 2015 1107 1115 30 Cerda B. Ceron J.J. Tomas-Barberan F.A. Espin J.C. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic J. Agric. Food Chem. 51 11 2003 3493 3501 12744688 31 Meerts I.A. Verspeek-Rip C.M. Buskens C.A. Keizer H.G. Bassaganya-Riera J. Jouni Z.E. van Huygevoort A.H. van Otterdijk F.M. van de Waart E.J. Toxicological evaluation of pomegranate seed oil Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc. 47 6 2009 1085 1092 32 Patel C. Dadhaniya P. Hingorani L. Soni M.G. Safety assessment of pomegranate fruit extract: acute and subchronic toxicity studies Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc. 46 8 2008 2728 2735 33 Cho Y.E. Lee M.H. Song B.J. Neuronal cell death and degeneration through increased nitroxidative stress and tau phosphorylation in HIV-1 transgenic rats PloS One 12 1 2017 e0169945 28107387 34 Cho Y.E. Mezey E. Hardwick J.P. Salem N. Jr. Clemens D.L. Song B.J. Increased ethanol-inducible cytochrome P450-2E1 and cytochrome P450 isoforms in exosomes of alcohol-exposed rodents and patients with alcoholism through oxidative and endoplasmic reticulum stress Hepatol. Commun. 1 7 2017 675 690 29404485 35 Celik G. Semiz A. Karakurt S. Arslan S. Adali O. Sen A. A comparative study for the evaluation of two doses of ellagic acid on hepatic drug metabolizing and antioxidant enzymes in the rat BioMed. Res. Int. 2013 2013 358945 23971029 36 Rosillo M.A. Sanchez-Hidalgo M. Cardeno A. Aparicio-Soto M. Sanchez-Fidalgo S. Villegas I. de la Lastra C.A. Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats Pharmacol. Res. 66 3 2012 235 242 22677088 37 Rodriguez J. Caille O. Ferreira D. Francaux M. Pomegranate extract prevents skeletal muscle of mice against wasting induced by acute TNF-alpha injection Mol. Nutr. Food Res. 61 4 2017 38 Sohn E.H. Koo H.J. Hang D.T.T. Jang S.A. Namkoong S. Lim J.D. Kang S.C. Protective effects of ellagic acid on ethanol-induced toxicity in hepatic HepG2 cells Mol. Cell. Toxicol. 9 3 2013 249 256 39 Lu Y. Zhuge J. Wang X. Bai J. Cederbaum A.I. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice Hepatology 47 5 2008 1483 1494 18393316 40 Song B.J. Akbar M. Abdelmegeed M.A. Byun K. Lee B. Yoon S.K. Hardwick J.P. Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications Redox Biol. 3 2014 109 123 25465468 41 McKim S.E. Gabele E. Isayama F. Lambert J.C. Tucker L.M. Wheeler M.D. Connor H.D. Mason R.P. Doll M.A. Hein D.W. Arteel G.E. Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice Gastroenterology 125 6 2003 1834 1844 14724835 42 Wang X. Lu Y. Cederbaum A.I. Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice Hepatology 42 2 2005 400 410 16025513 43 Yang L. Wu D. Wang X. Cederbaum A.I. Cytochrome P4502E1, oxidative stress, JNK, and autophagy in acute alcohol-induced fatty liver Free Radic. Biol. Med. 53 5 2012 1170 1180 22749809 44 Kathirvel E. Chen P. Morgan K. French S.W. Morgan T.R. Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver J. Gastroenterol. Hepatol. 25 6 2010 1136 1143 20594230 45 Kathirvel E. Morgan K. French S.W. Morgan T.R. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease Eur. J. Gastroenterol. Hepatol. 21 9 2009 973 983 19307976 46 Forsyth C.B. Voigt R.M. Keshavarzian A. Intestinal CYP2E1: a mediator of alcohol-induced gut leakiness Redox Biol. 3 2014 40 46 25462064 47 Abdelmegeed M.A. Song B.J. Functional roles of protein nitration in acute and chronic liver diseases Oxid. Med. Cell. Longev. 2014 2014 149627 24876909 48 Kannarkat G.T. Tuma D.J. Tuma P.L. Microtubules are more stable and more highly acetylated in ethanol-treated hepatic cells J. Hepatol. 44 5 2006 963 970 16169115 49 Lee Y.J. Shukla S.D. Histone H3 phosphorylation at serine 10 and serine 28 is mediated by p38 MAPK in rat hepatocytes exposed to ethanol and acetaldehyde Eur. J. Pharmacol. 573 1–3 2007 29 38 17643407 50 Pal-Bhadra M. Bhadra U. Jackson D.E. Mamatha L. Park P.H. Shukla S.D. Distinct methylation patterns in histone H3 at Lys-4 and Lys-9 correlate with up- & down-regulation of genes by ethanol in hepatocytes Life Sci. 81 12 2007 979 987 17826801 51 Shepard B.D. Tuma P.L. Alcohol-induced protein hyperacetylation: mechanisms and consequences World J. Gastroenterol. 15 10 2009 1219 1230 19291822 52 Dara L. Ji C. Kaplowitz N. The contribution of endoplasmic reticulum stress to liver diseases Hepatology 53 5 2011 1752 1763 21384408 53 Gentile C.L. Frye M.A. Pagliassotti M.J. Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease BioFactors 37 1 2011 8 16 21328622 54 Ji C. New insights into the pathogenesis of alcohol-induced ER stress and liver diseases Int. J. Hepatol. 2014 2014 513787 24868470 55 Malhi H. Kaufman R.J. Endoplasmic reticulum stress in liver disease J. Hepatol. 54 4 2011 795 809 21145844 56 Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond Nat. Rev. Mol. Cell Biol. 13 2 2012 89 102 22251901 57 Neunlist M. Van Landeghem L. Mahe M.M. Derkinderen P. des Varannes S.B. Rolli-Derkinderen M. The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease, Nature reviews Gastroenterol. Hepatol. 10 2 2013 90 100 58 Frazier T.H. DiBaise J.K. McClain C.J. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury J. Parenter. Enter. Nutr. 35 5 Suppl 2011 14S 20S 59 Spruss A. Kanuri G. Wagnerberger S. Haub S. Bischoff S.C. Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice Hepatology 50 4 2009 1094 1104 19637282 60 Carter S.R. Zahs A. Palmer J.L. Wang L. Ramirez L. Gamelli R.L. Kovacs E.J. Intestinal barrier disruption as a cause of mortality in combined radiation and burn injury Shock 40 4 2013 281 289 24045418 61 Thotala D. Chetyrkin S. Hudson B. Hallahan D. Voziyan P. Yazlovitskaya E. Pyridoxamine protects intestinal epithelium from ionizing radiation-induced apoptosis Free Radic. Biol. Med. 47 6 2009 779 785 19540915 62 White J.F. Intestinal pathophysiology in autism Exp. Biol. Med. 228 6 2003 639 649 63 Alhasson F. Das S. Seth R. Dattaroy D. Chandrashekaran V. Ryan C.N. Chan L.S. Testerman T. Burch J. Hofseth L.J. Horner R. Nagarkatti M. Nagarkatti P. Lasley S.M. Chatterjee S. Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation PloS One 12 3 2017 e0172914 28328972 64 Bull-Otterson L. Feng W. Kirpich I. Wang Y. Qin X. Liu Y. Gobejishvili L. Joshi-Barve S. Ayvaz T. Petrosino J. Kong M. Barker D. McClain C. Barve S. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment PloS One 8 1 2013 e53028 23326376 65 Hartmann P. Chen P. Wang H.J. Wang L. McCole D.F. Brandl K. Starkel P. Belzer C. Hellerbrand C. Tsukamoto H. Ho S.B. Schnabl B. Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice Hepatology 58 1 2013 108 119 23408358 66 Wang L. Fouts D.E. Starkel P. Hartmann P. Chen P. Llorente C. DePew J. Moncera K. Ho S.B. Brenner D.A. Hooper L.V. Schnabl B. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation Cell host Microbe 19 2 2016 227 239 26867181 67 Yan A.W. Fouts D.E. Brandl J. Starkel P. Torralba M. Schott E. Tsukamoto H. Nelson K.E. Brenner D.A. Schnabl B. Enteric dysbiosis associated with a mouse model of alcoholic liver disease Hepatology 53 1 2011 96 105 21254165 68 Bialonska D. Ramnani P. Kasimsetty S.G. Muntha K.R. Gibson G.R. Ferreira D. The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota Int. J. Food Microbiol. 140 2–3 2010 175 182 20452076 69 Gonzalez-Sarrias A. Romo-Vaquero M. Garcia-Villalba R. Cortes-Martin A. Selma M.V. Espin J.C. The endotoxemia marker lipopolysaccharide-binding protein is reduced in overweight-obese subjects consuming pomegranate extract by modulating the gut microbiota: a randomized clinical trial Mol. Nutr. Food Res. 2018 e1800160 29665619 70 Abdelmegeed M.A. Jang S. Banerjee A. Hardwick J.P. Song B.J. Robust protein nitration contributes to acetaminophen-induced mitochondrial dysfunction and acute liver injury Free Radic. Biol. Med. 60 2013 211 222 23454065 71 Abdelmegeed M.A. Moon K.H. Chen C. Gonzalez F.J. Song B.J. Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity Biochem. Pharmacol. 79 1 2010 57 66 19660437 72 Kahya V. Meric A. Yazici M. Yuksel M. Midi A. Gedikli O. Antioxidant effect of pomegranate extract in reducing acute inflammation due to myringotomy J. Laryngol. Otol. 125 4 2011 370 375 21349238 73 Kilic E. Turkoglu A. Keles A. Ekinci A. Kesgin S. Gumus M. The antioxidant effects of pomegranate extract on local and remote organs in a mesenteric ischemia and reperfusion model Redox Rep.: Commun. Free Radic. Res. 2015 74 Kumar D. Singh S. Singh A.K. Rizvi S.I. Pomegranate (Punica granatum) peel extract provides protection against mercuric chloride-induced oxidative stress in Wistar strain rats Pharm. Biol. 51 4 2013 441 446 23336580 75 Faria A. Monteiro R. Mateus N. Azevedo I. Calhau C. Effect of pomegranate (Punica granatum) juice intake on hepatic oxidative stress Eur. J. Nutr. 46 5 2007 271 278 17514376 76 Colombo E. Sangiovanni E. Dell'agli M. A review on the anti-inflammatory activity of pomegranate in the gastrointestinal tract Evid.-Based Complement. Altern. Med.: eCAM 2013 2013 247145 77 Hollebeeck S. Winand J. Herent M.F. During A. Leclercq J. Larondelle Y. Schneider Y.J. Anti-inflammatory effects of pomegranate (Punica granatum L.) husk ellagitannins in caco-2 cells, an in vitro model of human intestine Food Funct. 3 8 2012 875 885 22733173 78 Neyrinck A.M. Van Hee V.F. Bindels L.B. De Backer F. Cani P.D. Delzenne N.M. Polyphenol-rich extract of pomegranate peel alleviates tissue inflammation and hypercholesterolaemia in high-fat diet-induced obese mice: potential implication of the gut microbiota Br. J. Nutr. 109 5 2013 802 809 22676910 79 Rosenblat M. Aviram M. Pomegranate juice protects macrophages from triglyceride accumulation: inhibitory effect on DGAT1 activity and on triglyceride biosynthesis Ann. Nutr. Metab. 58 1 2011 1 9